SCCA’s Dr. Petros Grivas spoke on phase III JAVELIN Bladder 100 Trial

SCCA’s Dr. Petros Grivas spoke on phase III JAVELIN Bladder 100 Trial, to be presented at #ASCO20 plenary session. More information on results of this clinical trial on our SCCA at ASCO page here: www.seattlecca...

[@silvialogan9226]

This is very interesting because it is good to try new treatments on terminal cancer patients to see how they respond to the new treatments instead of always the standard surgery, radiation, and chemotherapy.